BDX vs PLUR · P/E 34, rev $21.84B vs rev $1.3M
Becton Dickinson and Company (BDX) versus Pluri Inc. (PLUR) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Pluri Inc. (PLUR) is a biotechnology company listed on NASDAQ.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported PLUR revenue for 2025-06-30 was $1.3M. Net income was -$23.3M. Revenue was up 309.8% from 2024-06-30 to 2025-06-30. PLUR currently screens at market cap $24.3M.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. PLUR currently screens at market cap $24.3M.
Not investment advice. Open the BDX and PLUR stock pages for the full models.
Not investment advice.